Gastroliver - GLEC
Care SegmentONCOLOGICAL GI SURVEILLANCE

Early Gastro Cancer Detection

Most stomach, esophageal, and colorectal cancers do not start as cancer; they begin as benign, slow-growing polyps or mucosal dysplasia over 5 to 10 years. Our specialized cancer detection pathway utilizes optical chromoendoscopy to identify and remove pre-cancerous growths on the spot, achieving over 90% curative outcomes.

Stomach CancerColon PolypsScreening ColonoscopyBarrett’s EsophagusOptical BiopsyEarly Detection
Quick WhatsApp Inquiry
Early Gastro Cancer Detection
CLINICAL OVERVIEW & APPROACH

Curative Screening & Pre-Cancerous Prevention

Gastrointestinal cancers (including colon, stomach, and esophagus) are among the most treatable malignancies in the world, provided they are detected early. Advanced optical imaging allows Dr. Ankita Gupta to examine cellular microvascular patterns and excise pre-malignant polyps scarlessly.

Colon polyps can be completely removed during colonoscopy (Polypectomy) preventing cancer entirely
Japanese Narrow Band Imaging (NBI) reveals abnormal capillaries invisible under conventional white light
Comprehensive risk-stratified surveillance for individuals with family history of gastrointestinal cancers
CARE SEGMENT SERVICES

Specialized Diagnostic & Clinical Protocols

Every patient follows a structured, evidence-based pathway designed to eliminate guesswork and restore health.

Preventive Screening Colonoscopy

Recommended globally from age 45. Detects and removes adenomatous polyps before they can undergo malignant transformation.

  • Cold snare polypectomy for instant polyp excision
  • Histopathological laboratory analysis of all resected tissue
  • Tailored recall interval (e.g. 5-10 years based on risk)

Narrow Band Imaging (NBI) Optical Biopsy

Special optical filters highlight superficial mucosal blood vessels to pinpoint early neoplasia and gastric intestinal metaplasia.

  • Micro-vascular pattern classification
  • Distinguishes benign hyperplastic polyps from adenomas
  • Zero-delay diagnostic precision

Barrett’s Esophagus Surveillance

Specialized protocol for long-standing acid reflux patients to monitor cellular changes in the lower esophagus.

  • Seattle biopsy protocol for high-grade dysplasia
  • Endoscopic surveillance preventing esophageal adenocarcinoma
  • Acid suppression optimization

H. Pylori Eradication & Gastric Cancer Prevention

Helicobacter Pylori is classified as a Group 1 human carcinogen by the WHO. Eradicating it drastically cuts stomach cancer risk.

  • Rapid urease biopsy testing during gastroscopy
  • Triple/quadruple eradication medical therapy
  • Stool antigen test confirming complete cure

When to Seek Expert Evaluation

Do not wait for symptoms to escalate. Consult Dr. Ankita Gupta if you experience:

Age 45 or older (international guideline for baseline screening colonoscopy)
Family history of colon cancer, stomach cancer, or colorectal polyps in first-degree relatives
Unexplained blood in stool (bright red, maroon, or black tarry stools)
Chronic acid reflux for more than 5 years (screening for Barrett’s esophagus)
Unexplained weight loss, new-onset persistent abdominal pain, or unexplained anemia
Physician Perspective
Colon cancer is almost uniquely preventable because it arises from benign polyps that take years to grow. When we find and remove a polyp during a routine colonoscopy, we have literally stopped cancer before it could ever begin.
AG

Dr. Ankita Gupta

Gold Medalist Gastroenterologist & Advanced Endoscopist
STRUCTURED WORKFLOW

Your Care Journey with Us

A clear, predictable roadmap from initial consultation to complete recovery.

01

Oncological Risk Stratification

Review of personal risk factors, family pedigree, dietary habits, and previous endoscopy records.

02

Advanced Optical Screening

High-definition colonoscopy or upper endoscopy with Dual Focus NBI under painless twilight sedation.

03

Same-Session Curative Resection

Any detected polyps or abnormal mucosal patches are painlessly resected (Polypectomy/EMR) immediately.

04

Pathology & Personalized Surveillance

Detailed histology review defining exact surveillance intervals to guarantee lifelong peace of mind.

PATIENT QUESTIONS

Frequently Asked Questions

International gastroenterology guidelines recommend baseline screening starting at age 45 for average-risk individuals, and age 40 (or 10 years earlier than the youngest affected relative) for those with a family history.
ALL CARE PATHWAYS

Explore Other Care Segments

Navigate across our specialized clinical pathways to discover targeted diagnostics and treatments.

Ready to Discuss Your Care Pathway?

Book an in-person or virtual consultation with Gold Medalist Dr. Ankita Gupta at Gastro Liver Endoscopy Centre, Greater Kailash, New Delhi.

Call +91 98111 24458